Effects of Melatonin on Insomnia Symptoms in Older Adults

NCT00230737 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2017-03-08

Study results available
· View outcomes & findings →

Summary

This study will determine whether melatonin tablets will increase the sleep of older adults with insomnia.

Conditions

  • Sleep Initiation and Maintenance Disorders

Interventions

DRUG

Melatonin 0.4 mg

DRUG

Melatonin 4.0 mg

DRUG

Placebo

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH
  • Nalaka Gooneratne

    lead OTHER

Principal Investigators

  • Nalaka S. Gooneratne, MD,MSc · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00230737 on ClinicalTrials.gov